Clinical significance and potential application of cuproptosis-related genes in gastric cancer

doi:10.4251/wjgo.v15.i7.1200

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1900)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-3) series.

Item

Count

PDF

WORD

HTML

1153

Figures (1-6)

140

Tables (1-3)

102

Sum=1477

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

236

Sum=332

Jul 15, 2023 (publication date) through May 11, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Jul 15, 2023; 15(7): 1200-1214
Published online Jul 15, 2023. doi: 10.4251/wjgo.v15.i7.1200

Table 3 Potential perturbagens of interactive prognostic cuproptosis-related genes

Perturbagen	Moa	Raw_cs	FDR_q_nlog 10
Fluconazole	Sterol demethylase inhibitor	0.79	1.03
KD-025	Rho associated kinase inhibitor	0.77	0.95
Clofarabine	Ribonucleoside reductase inhibitor	0.76	0.89
Tramadol	Opioid receptor agonist, Norepinephrine reuptake inhibitor, Serotonin reuptake inhibitor	0.76	0.89
Doxorubicin	Topoisomerase inhibitor	0.75	0.88
AXD-5438	CDK inhibitor	0.73	0.80
BRD-K67174965	Mucolytic	0.73	0.79
Faropenem	Lactamase inhibitor	0.72	0.76
Clocortolone-pivalate	Steroid	0.72	0.68
Ganglioside	Src activator	0.71	0.46

Citation: Yan JN, Guo LH, Zhu DP, Ye GL, Shao YF, Zhou HX. Clinical significance and potential application of cuproptosis-related genes in gastric cancer. World J Gastrointest Oncol 2023; 15(7): 1200-1214
URL: https://www.wjgnet.com/1948-5204/full/v15/i7/1200.htm
DOI: https://dx.doi.org/10.4251/wjgo.v15.i7.1200